Brief: CStone Pharmaceuticals Posts Loss For Six Months RMB209.2 Million
15/08/2023 16:46
Aug 15 (Reuters) - CStone Pharmaceuticals 2616.HK :
* LOSS FOR SIX MONTHS RMB209.2 MILLION VERSUS LOSS RMB361.6
MILLION
* HY REVENUE RMB261.5 MILLION VERSUS RMB261.8 MILLION
Further company coverage: 2616.HK
((reuters.briefs@thomsonreuters.com;))
Recent news on CStone Pharmaceuticals
See all newsBrief: CStone Pharmaceuticals Says CEO Purchases 496,000 Shares For Over HK$2.7 Million From Sept 17-22
Brief: CStone Pharmaceuticals Posts HY Loss Of Rmb252.3 Million
China's CStone Pharmaceuticals H1 revenue soars on drug sales
Brief: Cstone Pharmaceuticals Receives NMPA IND Approval For CS5007 In China
Brief: CStone Pharmaceuticals Says Directors And Senior Management Purchase 2.4 Million Shares In June 2026